- Home
- KZR vs UG Comparison
KZR vs UG Comparison
Compare KZR & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZR
- UG
- Stock Information
- Founded
- KZR 2015
- UG 1942
- Country
- KZR United States
- UG United States
- Employees
- KZR N/A
- UG 25
- Industry
- KZR Biotechnology: Pharmaceutical Preparations
- UG Package Goods/Cosmetics
- Sector
- KZR Health Care
- UG Consumer Discretionary
- Exchange
- KZR Nasdaq
- UG Nasdaq
- Market Cap
- KZR 54.1M
- UG 45.5M
- IPO Year
- KZR 2018
- UG N/A
- Fundamental
- Price
- KZR $6.43
- UG $9.83
- Analyst Decision
- KZR Hold
- UG
- Analyst Count
- KZR 2
- UG 0
- Target Price
- KZR $11.00
- UG N/A
- AVG Volume (30 Days)
- KZR 61.0K
- UG 12.1K
- Earning Date
- KZR 11-12-2024
- UG 11-08-2024
- Dividend Yield
- KZR N/A
- UG 6.06%
- EPS Growth
- KZR N/A
- UG 38.11
- EPS
- KZR N/A
- UG 0.76
- Revenue
- KZR N/A
- UG $12,312,275.00
- Revenue This Year
- KZR N/A
- UG N/A
- Revenue Next Year
- KZR N/A
- UG N/A
- P/E Ratio
- KZR N/A
- UG $13.04
- Revenue Growth
- KZR N/A
- UG 11.51
- 52 Week Low
- KZR $5.20
- UG $6.75
- 52 Week High
- KZR $11.40
- UG $16.25
- Technical
- Relative Strength Index (RSI)
- KZR 28.75
- UG 42.35
- Support Level
- KZR $6.80
- UG $9.70
- Resistance Level
- KZR $7.04
- UG $9.95
- Average True Range (ATR)
- KZR 0.24
- UG 0.27
- MACD
- KZR -0.06
- UG 0.14
- Stochastic Oscillator
- KZR 0.00
- UG 58.18
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.